Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.66B |
| 2 |
NVIDIA
NVDA
|
+$879M |
| 3 |
Apple
AAPL
|
+$827M |
| 4 |
Broadcom
AVGO
|
+$821M |
| 5 |
Shopify
SHOP
|
+$684M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$681M |
| 2 |
UnitedHealth
UNH
|
+$572M |
| 3 |
Meta Platforms (Facebook)
META
|
+$486M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 5 |
Netflix
NFLX
|
+$447M |
Sector Composition
| 1 | Technology | 26.48% |
| 2 | Financials | 12.84% |
| 3 | Industrials | 11.84% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Kymera Therapeutics
KYMR
$3.28B
| $2.09M | ﹤0.01% |
47,884
+5,809
| +14% | +$254K |
|
2502
Arcellx
ACLX
$4.26B
| $2.09M | ﹤0.01% |
31,681
+1,439
| +5% | +$94.8K |
|
2503
LegalZoom.com
LZ
$1.89B
| $2.08M | ﹤0.01% |
233,610
+33,658
| +17% | +$300K |
|
2504
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $2.07M | ﹤0.01% |
44,900
-25,884
| -37% | -$1.2M |
|
2505
PDF Solutions
PDFS
$784M
| $2.07M | ﹤0.01% |
96,897
+6,560
| +7% | +$140K |
|
2506
Peoples Bancorp
PEBO
$1.09B
| $2.07M | ﹤0.01% |
67,703
-9,389
| -12% | -$287K |
|
|
STR
2507
DELISTED
Sitio Royalties
STR
| $2.07M | ﹤0.01% |
112,379
+3,699
| +3% | +$68K |
|
|
DBL
2508
DoubleLine Opportunistic Credit Fund
DBL
$296M
| $2.05M | ﹤0.01% |
133,465
-17,850
| -12% | -$275K |
|
2509
ARS Pharmaceuticals
SPRY
$1.01B
| $2.05M | ﹤0.01% |
117,500
+87,551
| +292% | +$1.53M |
|
2510
Arcus Biosciences
RCUS
$1.23B
| $2.05M | ﹤0.01% |
251,851
-2,173
| -0.9% | -$17.7K |
|
2511
HighPeak Energy
HPK
$911M
| $2.05M | ﹤0.01% |
209,137
+9,444
| +5% | +$92.6K |
|
2512
Vir Biotechnology
VIR
$731M
| $2.04M | ﹤0.01% |
404,852
-728
| -0.2% | -$3.67K |
|
2513
Trump Media & Technology Group
DJT
$4.74B
| $2.04M | ﹤0.01% |
112,855
+48,199
| +75% | +$870K |
|
2514
German American Bancorp
GABC
$1.53B
| $2.03M | ﹤0.01% |
52,718
-600
| -1% | -$23.1K |
|
2515
Galicia Financial Group
GGAL
$5.01B
| $2.02M | ﹤0.01% |
40,072
-278
| -0.7% | -$14K |
|
2516
SFL Corp
SFL
$1.1B
| $2M | ﹤0.01% |
239,995
-76,289
| -24% | -$635K |
|
2517
CEMIG Preferred Shares
CIG
$5.81B
| $1.97M | ﹤0.01% |
1,005,819
-109,096
| -10% | -$214K |
|
|
NHS
2518
Neuberger Berman High Yield Strategies Fund
NHS
$233M
| $1.96M | ﹤0.01% |
258,944
+8,676
| +3% | +$65.8K |
|
2519
Calamos Strategic Total Return Fund
CSQ
$3.06B
| $1.96M | ﹤0.01% |
107,541
+8,232
| +8% | +$150K |
|
2520
QCR Holdings
QCRH
$1.31B
| $1.95M | ﹤0.01% |
28,728
-37,202
| -56% | -$2.53M |
|
2521
Mach Natural Resources
MNR
$1.62B
| $1.93M | ﹤0.01% |
133,944
-17,089
| -11% | -$247K |
|
2522
BlackRock MuniHoldings Fund
MHD
$611M
| $1.93M | ﹤0.01% |
172,436
+48,644
| +39% | +$545K |
|
2523
Fastly
FSLY
$1.15B
| $1.93M | ﹤0.01% |
273,472
+49,280
| +22% | +$348K |
|
2524
SK Telecom
SKM
$8.36B
| $1.93M | ﹤0.01% |
82,566
-333
| -0.4% | -$7.78K |
|
2525
Ecovyst
ECVT
$1.04B
| $1.92M | ﹤0.01% |
233,636
-17,027
| -7% | -$140K |
|